Journal article icon

Journal article

Morphological and biochemical characterization of influenza vaccines commercially available in the United Kingdom.

Abstract:
Four vaccines are available in the United Kingdom against influenza virus. All are subunit vaccines, defined as either split-virion or purified surface antigen vaccine; there are two of each distinct type available. Both vaccine types are less reactogenic than whole inactivated virus, with antigenicity induced by viral surface glycoproteins. Here, each of the four vaccines has been characterized by electron microscopy and SDS-PAGE analysis, giving a unique vaccine profile. Three vaccines contain internal viral nucleoprotein which, in the presence of residual haemagglutinin, may induce an influenza A virus cross-reactive cytotoxic T-cell response and thus be of value to vaccine efficacy. Residual lipid was present in three vaccines and recent evidence suggests that pyrogenicity is correlated with the presence of viral lipid with clusters of surface glycoproteins. By a combination of electron microscopic evidence and biochemical characterization, it has been possible to resolve compositional differences, not only between vaccine type, but also between each individual currently available vaccine. Hence, there is the possibility that the morphological differences characterized here may be contributory to potential reactogenic effects subsequent to vaccination.
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1016/0264-410x(94)90227-5

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Biochemistry
Role:
Author


Journal:
Vaccine More from this journal
Volume:
12
Issue:
8
Pages:
747-752
Publication date:
1994-06-01
DOI:
EISSN:
1873-2518
ISSN:
0264-410X


Language:
English
Keywords:
Pubs id:
pubs:422131
UUID:
uuid:ebaf2b41-1315-427d-bb85-ec787a7dd11c
Local pid:
pubs:422131
Source identifiers:
422131
Deposit date:
2013-11-17

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP